Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic studies reveal Jak2 is not essential for platelet production
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Evaluation of Cepheid Norovirus assay for detection of noroviruses genogroup I and II in stool
    Meeting Abstract

    McMillen, T.; Chen, J.; Sun, J.; Nie, S.; Fan, F.; Babady, N.; Tang, Y.
    Journal of Molecular Diagnostics (2014)

    Fulltext@MSK | Save
  • A phase Ib dose escalation trial of sar650984 (anti-cd-38 mab) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma
    Meeting Abstract

    Martin, T.; Baz, R.; Benson, D.; Lendvai, N.; Vij, R.; Charpentier, E.; Hsu, K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Genetic correction of differently mobilized hematopoietic stem cells from patients with thalassemia and engraftment kinetics after xenotransplantation
    Meeting Abstract

    Karponi, G.; Papayanni, P.; Lederer, C. W.; Psatha, N.; Zervou, F.; Zogas, N.; Tsatalas, C.; Anagnostopoulos, A.; Sadelain, M.; Riviere, I.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Pre-treatment with idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL
    Meeting Abstract

    Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor (tki) switching: Experience from simplicity, a prospective observational study of chronic-phase chronic myeloid leukemia (cp-cml) patients in clinical practice
    Meeting Abstract

    Hehlmann, R.; Cortes, J.; Gambacorti-Passerini, C.; Goldberg, S. L.; Khoury, H. J.; Mauro, M.; Michallet, M.; Mohamed, H.; Powell, T.; Paquette, R.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Pre-treatment with Idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL
    Meeting Abstract

    Hallek, M.; Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • 2nd analysis of a phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of Idelalisib and Rituximab for previously treated patients with chronic lymphocytic leukemia
    Meeting Abstract

    Hallek, M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; more...
    Oncology Research and Treatment (2014)

    Fulltext@MSK | Save
  • Acceleration of BCR-ABL+ leukemia induced by deletion of JAK2
    Meeting Abstract

    Grundschober, E.; Hoelbl-Kovacic, A.; Bhagwat, N.; Levine, R.; Sexl, V.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Effect of idelalisib/rituximab combination treatment of relapsed cll on the bcr signaling-related chemokines ccl3 and ccl4: Data from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Ghia, P.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save